Access to Codexis information for the investment community
Q4 2014 Codexis, Inc. Earnings Conference Call (Live)
03/03/15 at 1:30 p.m. PT
Codexis, Inc. (Nasdaq: CDXS), is a leading developer of biocatalysts for the pharmaceutical and fine chemical industries. Codexis utilizes its proprietary CodeEvolver® directed evolution technology platform and CodeXporter® enzyme production platform, for the discovery, identification, optimization, and efficient production of enzymes for its customers. Customers include global leaders such as Merck, Pfizer and Teva. For more information, see www.codexis.com
|View more events >>|
|Sign up for E-mail Alerts|
Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.